103 related articles for article (PubMed ID: 1063065)
1. Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate.
Wang JJ; Freeman AI; Sinks LF
Cancer Res; 1976 Apr; 36(4):1441-4. PubMed ID: 1063065
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate in acute lymphocytic leukemia.
Freeman AI; Wang JJ; Sinks LF
Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
Shapiro WR; Young DF; Mehta BM
N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
[TBL] [Abstract][Full Text] [Related]
5. The prevention of methotrexate toxicity by thymidine infusions in humans.
Ensminger WD; Frei E
Cancer Res; 1977 Jun; 37(6):1857-63. PubMed ID: 870189
[TBL] [Abstract][Full Text] [Related]
6. [Methotrexate levels in the blood and cerebrospinal fluid in children with acute lymphoid leukemia treated with medium doses of methotrexate].
Borsi J; Koós R; Révész T; Schuler D
Orv Hetil; 1984 Oct; 125(44):2667-8, 2671-3. PubMed ID: 6387586
[No Abstract] [Full Text] [Related]
7. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.
Evans WE; Crom WR; Abromowitch M; Dodge R; Look AT; Bowman WP; George SL; Pui CH
N Engl J Med; 1986 Feb; 314(8):471-7. PubMed ID: 3456079
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
10. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukaemia in Norway. Report on a national treatment program.
Moe PJ; Seip M; Finne PH
Haematologia (Budap); 1981; 14(3):257-63. PubMed ID: 6948760
[TBL] [Abstract][Full Text] [Related]
11. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
12. [New aspects of the determination of blood methotrexate levels in leukemic children].
Schuler D; Borsi J; Koós R; Révész T; Kardos G; Somló P
Monatsschr Kinderheilkd; 1986 Oct; 134(10):765-8. PubMed ID: 3467178
[TBL] [Abstract][Full Text] [Related]
13. [End results and comparative analysis of treatment programs for childhood acute lymphocytic leukemia].
Kawai S; Fujimoto T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):17-26. PubMed ID: 3467655
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
Fujimoto T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
[TBL] [Abstract][Full Text] [Related]
17. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
Pinkerton CR; Chessells JM
Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
[TBL] [Abstract][Full Text] [Related]
18. Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis.
Brecher ML; Berger P; Freeman AI; Krischer J; Boyett J; Glicksman AS; Foreman E; Harris M; Jones B; Cohen ME
Cancer; 1985 Nov; 56(10):2430-3. PubMed ID: 3862463
[TBL] [Abstract][Full Text] [Related]
19. Effect of the intermittent prophylactic treatment of the central nervous system in adults with acute leukemia.
Kawamura S; Mikami T; Iwamura H; Sawada Y; Yamaya T; Haneda Y; Sakata Y; Chiba Y; Yoshida Y
Biomed Pharmacother; 1987; 41(9-10):462-7. PubMed ID: 3482982
[TBL] [Abstract][Full Text] [Related]
20. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG
Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
